Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections
|
|
- Gervais Brooks
- 5 years ago
- Views:
Transcription
1 Available online at Technical Note: A Counting Strategy for Estimating Plasma Cell Number in CD138-Stained Bone Marrow Core Biopsy Sections Fred B. Smith and Ashraf Elnawawi Department of Pathology, Saint Vincent s Catholic Medical Centers of New York Manhattan, New York, and Department of Pathology, New York Medical College, Valhalla, New York Abstract. Plasma cells are readily identified microscopically after immunostaining for the CD138 antigen, and CD138-stained bone marrow core biopsy sections have proved superior to Giemsa-stained aspirate smears and hematoxylin-eosin (H&E) sections for determining plasma cell percentages in marrow. The CD138-stained plasma cell percentage is generally obtained by visual estimation, after viewing the entire section. We propose an alternative method, in which the microscopist initially views the immunostained section under low- and medium-power magnification, then selects a single high-power field in which the relative concentration of plasma cells appears most representative of the section as a whole, and performs a manual differential count of plasma cells in that field. On 44 CD138-stained core biopsy specimens from patients with plasma cell myeloma, selected area counting provided plasma cell percentage values that were more closely correlated with total section plasma cell area, determined by computerized image cytometry, than were visual estimates. This simple method requires only slightly more time than visual appraisal, does not require extensive training or experience, and appears to provide a more accurate estimate of the plasma cell population within the entire specimen. Keywords: plasma cell, plasma cell myeloma, immunohistochemistry, CD138 antigen Introduction Address correspondence to Fred B. Smith, M.D., Dept. of Pathology, St. Vincent s Catholic Medical Centers of New York, 170 West 12 Street, New York, NY 10011, USA; tel ; fax ; fsmith@svcmcny.org. The relative number of plasma cells in a bone marrow specimen is a clinical parameter important in the diagnosis and management of plasma cell dyscrasia [1]. The plasma cell number, expressed as a percentage of total marrow hematopoietic cells, has traditionally been obtained by manual differential counting of Giemsa-stained marrow aspirate smears (smear counts) or by estimation from H&E-stained core biopsy sections. CD138 antigen is expressed by neoplastic and nonneoplastic plasma cells, but not by other cells normally present in bone marrow, and the recent introduction into clinical practice of immunostaining for CD138 has greatly facilitated the recognition and quantitation of marrow plasma cells [2,3]. Estimated plasma cell percentages based on visual microscopic appraisal of entire CD138- stained marrow core biopsy sections (CD138 overview estimates) have been reported to show greater inter-observer reproducibility than those based on smear counts or H&E-section estimates, and to correlate well with plasma cell percentages obtained by image cytometry [4]. CD138 overview estimates presumably achieve these superior results because the immunostaining, unlike traditional methods, makes it possible to recognize plasma cells under low-magnification microscopy, when their numbers can be better judged in relation to other cells of the marrow. Although CD138 estimates have thus improved diagnostic accuracy, they must be assumed to be subject to particular sources of error generated by /08/ $ by the Association of Clinical Scientists, Inc.
2 Plasma cell estimation in core biopsy of bone marrow 139 visual overviews. Because plasma cells are larger than the majority of hematopoietic cells, one would expect the observer to be influenced by the relatively larger aggregate stained area of the plasma cells and therefore to tend systematically to overestimate their number. In addition, there is a risk that the accuracy of the estimate could be influenced by the distribution pattern of the plasma cells within the marrow, since this is known to vary widely among patients [5]. Perceptual psychologists have noted that when observers visually estimate the numbers of objects too numerous to count (numerosity estimates), they tend to underestimate numbers if the objects are clustered and to overestimate numbers if the objects are dispersed uniformly against the background [6,7]. One would expect the effect of this error to be magnified in plasma cell estimates by overview, since the percentage is derived as a ratio of two numerosity estimates, that of the total marrow cell population and of the stained plasma cells. In carrying out this study, we asked whether we could improve on the visual overview approach to CD138 plasma cell estimates by including a high-magnification manual counting step in the assessment, using the initial low-magnification overview only to select the counting area, and not attempting to estimate cell numbers on the overview. Assessment of CD138-stained core biopsy sections by selected area counting would thus closely parallel the steps used in performing smear counts. We retrospectively assessed CD138- stained bone marrow core biopsies from our departmental archives in this manner, and compared the results to those obtained previously by overview estimates and to those obtained by computerized image cytometry. Materials and Methods Case material. Archived histologic sections from bone marrow core biopsies on patients with plasma cell myeloma, which were performed in 2006 and stained previously for demonstration of CD138 antigen, were retrieved for review. Forty-four sections were judged technically adequate for purposes of the study (ie, marrow area >1 mm 2, cellularity >10%). The patient group from whom the biopsies had been obtained comprised 25 males and 19 females, and their mean age was 60.9 yr (SD ±10.7 yr). Serum total protein values ranged from 4.0 to 8.7 g/dl, and 28 patients had a detectable serum M-protein (11 IgG-κ, 5 IgA-κ, 4 IgG-λ, 2 IgA-λ, 6 other types), at concentrations of 0.08 to 2.16 g/dl. Twentytwo of the patients had detectable free light chains in the urine (23.9 to mg/l). Plasma cell estimates by visual overview and by smear counts were obtained from the surgical pathology reports on the biopsies. Overview estimates were listed on 42 of the pathology reports and smear counts on 32. The procedure for de-identification of the sections and reports, as well as the protocol for the entire study, was approved by the St. Vincent s Catholic Medical Centers of New York Integrated Scientific and Ethical Review Board. Plasma cell estimation by selected area counting. The sections were initially scanned at low (100x) and intermediate (200x) magnification to assess the distribution and concentration of the darkly stained plasma cells. An area within the section was then selected that was judged to have approximately the same concentration of plasma cells as the section as a whole. At high magnification (400x), a region containing approximately 200 cells was selected for counting, and delimited by use of the field diaphragm on the microscope light source. Plasma cells and other nucleated cells in the delimited region were counted with a manual cell counter, and the result was computed as plasma cell percentage. The method of field selection is illustrated in Fig. 1. Image cytometry. The sections were analyzed with a CAS 200 Image Analysis System, using Quantitative Nuclear Antigen software and 400x magnification. Digital images of all portions of the biopsy sections containing hematopoietic tissue were analyzed, with the nuclear threshold setting lowered so that both cytoplasm and nuclei of hematopoietic cells were included in the nuclear image. The antibody threshold was set so that only stained plasma cells were included in the antibody image, and the computed percent area score thus represented the aggregate area of plasma cells, as a percent of the total hematopoietic cell area, within the section. This method was previously used for quantitation of stained cells within a mixed tissue cell population [8]. Data analysis. Results from image cytometry and selected area counting were recorded in an MS Excel file, along with the corresponding overview estimates and smear counts from the pathology reports, and pairwise comparisons of methods were made with StatistXL software, using simple correlation and computations of Pearson s r and Student s t. Results Descriptive statistics for the plasma cell percentages obtained in the study cases by each of the methods (selected area counting, image cytometry, overview estimate, and smear count) are shown in Table 1. The mean of the aspirate smear counts was appreciably lower than the means obtained by the other methods; this may reflect the plasma cell stripping artifact in aspirate smears [3].
3 140 Table 1. Plasma cell percentage of the study cases, assessed by four methods. CD138 section overview Smear count Selected area count Image cytometry % area number mean ± SD 19.2 ± ± ± ± 10.7 range Fig. 1. Area selection for counting of CD138-positive plasma cells. Left, encircled area selected at intermediate-power magnification (200x) to contain concentration of plasma cells representative of section as a whole. Right, selected area at highpower magnification (400x), delimited using microscope field diaphragm. This area was found to contain 196 nucleated cells, 25 of which (13%) were plasma cells. Fig. 2. Correlation of plasma cell percentages by CD138 section overview, Giemsa-stained smear count, and CD138 section selected area count with plasma cell percent area (PA) score obtained by image cytometry.
4 Plasma cell estimation in core biopsy of bone marrow 141 Correlations between each of the manual method results with those obtained by image cytometry are shown in Fig. 2. Selected area counts were more highly correlated with the image cytometry measurements than were the smear counts or overview estimates. Although smear count percentages were lower than those obtained by overview estimates, they showed better correlation with image cytometry. Discussion In this study, selected area counts better approximated plasma cell numbers on CD138- stained bone marrow core biopsy sections than did visual overview estimates, with image cytometry measurements of plasma cell area as a gold standard for comparison. We believe this reflects, at least in part, a decreased impact of numerosity-related error in arriving at the final estimate of plasma cell percentage by the selected area count method. Although the area selection step is subjective and susceptible to observer bias, the counting step in the procedure is not. In overview estimation, however, the entire procedure is based on a subjective judgment. Smear counts in our study also outperformed overview estimates, based on image cytometry correlation, although they systematically undercounted plasma cells. This probably reflects both the partial objectivity of the method (only selection of the area of the smear for counting is subjective) and the under-representation of plasma cells in marrow aspirate samples, as previously noted [3]. It seems likely that the accuracy of CD138 overview estimates could be substantially increased by training the individuals who perform the estimates. Observers could initially examine a training set of marrow sections calibrated by image cytometry and then be provided with feedback on their estimates. In performing a similar visual estimation task, assessment of land areas from aerial overviews, observers dramatically improved their estimates when trained by feedback from image analysis [9]. In a study by Al-Quran et al [4], the reported CD138 overview estimates of plasma cells were performed by 2 individuals identified as expert hematopathologists, who may also have been experienced in image cytometry. We suspect that training effects may explain the much better correlation between overview estimates and image cytometry they reported, compared to our results. The overview estimates in our study were obtained from pathology reports and were provided by 4 general surgical pathologists, none of whom had previously performed image cytometry on marrow specimens. We believe that their estimates represent what would be expected from any conscientious microscopist not specifically trained for the task or aware of numerosity-related illusions. Judging from our experience, selected area counting appears to be a better means of assessing plasma cell numbers in CD138-stained marrow core biopsy sections of myeloma patients than overview estimation in the usual laboratory setting. We caution that our findings have not been tested in non-myeloma patients, and therefore may not pertain to normal patients or those with reactive plasmacytosis. We note, however, that the group of myeloma patients we studied included a subset in disease remission, with plasma cell numbers in the normal and reactive range. Until this issue has been explored more fully, we suggest that laboratories performing estimates of plasma cell numbers in bone marrow biopsies stained for CD138 antigen should not expect overview estimates to closely approximate the actual cell numbers, unless the individuals performing the estimates have been specially trained for this task. Performance of a selected area count on a CD138 section requires no special training and takes less time than a traditional smear count, and the results are not subject to the undercount bias inherent in assessing aspirate smears. References 1. Ravikumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Therneau TM, Kyle RA, Greipp PR, Gertz MA. Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol 2001;68: Chilosi M, Adami F, Lestani M, Montagna L, Cimarosto L, Semanzato G, Pizzolo G, Menestrina F. CD138/ syndecan-1: a useful immunohistochemical marker of
5 142 normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol 1999;12: Dunphy CH, Nies MK, Gabriel DA. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma. Appl Immunohistochem Mol Morphol 2007; 15: Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas- Nikitin VK. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Human Pathol 2007; 38: Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987;87: Ginsburg N. Numerosity estimation as a function of stimulus organization. Perception 1991;20: Cousins JB, Ginsburg N. Subject correlation and the regular-random numerosity illusion. J Gen Psychol 1983;108: Smith FB, Arias JH, Elmquist TH, Mazzara JT. Microvascular cytomegalovirus endothelialitis of the lung. A possible cause of secondary pulmonary hypertension in a patient with AIDS. Chest 1998;114: Gallegos A. Design and evaluation of a computer aided calibration program for visual estimation of vegetation cover. Sveriges Landtbruksuniversitet Arbetsrapport , accessed 10/5/2007 at se/resana/nils/publikationer/arb_rapp_142.pdf.
The diagnosis and classification of plasma cell dyscrasias
Quantitation of Plasma Cells in Bone Marrow Aspirates by Flow Cytometric Analysis Compared With Morphologic Assessment Kristi J. Smock, MD; Sherrie L. Perkins, MD, PhD; David W. Bahler, MD, PhD Context.
More informationGuidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology
Guidelines for the diagnosis of Multiple Myeloma 2014 By:British Committee for Standards in Haematology (BCSH) Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Diagnosis, prognostic factors and disease monitoring
More informationUniform Labeling of Blocks and Slides in Surgical Pathology
Uniform Labeling of Blocks and Slides in Surgical Pathology Guideline from the College of American Pathologists and the National Society for Histotechnology Published : Archives of Pathology and Laboratory
More informationClinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma Robert A. Kyle, M.D., Ellen D. Remstein, M.D., Terry
More informationSingle Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells
Hematopathology / Flow Cytometric Analysis of Clonal Plasma Cells Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells Derek K. Marsee,
More informationJune Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD
June 2011 Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD In this issue we review the laboratory work up of patients suspected of having a plasma cell neoplasm. As the range in clinical
More informationComparing the Quality of Fixation for Gel-based Formalin (Formagel) versus Traditional Liquid-Based Formalin for Immunohistochemistry
Comparing the Quality of Fixation for Gel-based Formalin (Formagel) versus Traditional Liquid-Based Formalin for Immunohistochemistry Brian H. Le, M.D., Reading Hospital Reviewed by Michael R. LaFrinere,
More informationAssessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population
Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol 36, no. 2, 2006 157 Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs
More informationFreelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies
Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Montgomery Lobe, MD, and Donald Pasquale, MD Abstract Monoclonal gammopathies are characterized by production of monoclonal
More informationStem Cells and Multiple Myeloma
Stem Cells and Multiple Myeloma What is Multiple Myeloma Multiple Myeloma is a cancer of your plasma cells, a type of white blood cell present in your bone marrow Plasma cells normally make proteins called
More informationبسم اهلل الرمحن الرحيم
بسم اهلل الرمحن الرحيم Definition Multiple myeloma is a neoplastic plasma cell dyscrasia (PCD) that generally produced a monoclonal immunoglobulin protein, characterized by a clinical pentad: (a) anemia;
More informationTheraLin. Universal Tissue Fixative Enabling Molecular Pathology
TheraLin Universal Tissue Fixative Enabling Molecular Pathology TheraLin Universal Tissue Fixative Enabling Molecular Pathology Contents Page # TheraLin Universal Tissue Fixative 3 Introduction 5 Easy
More informationThe histopathology of myeloma in the bone marrow
Journal of clinical and experimental hematopathology Vol. 58 No.2, 61-67, 2018 JC lin EH xp ematopathol Review Article The histopathology of myeloma in the bone marrow Masahiko Fujino Myeloma is characterized
More informationCAP Accreditation Checklists 2016 Edition
CAP Accreditation Checklists 2016 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
More informationImage Analysis. Tools for basic and translational research. visualize analyze interpret report archive customize
Image Analysis Tools for basic and translational research visualize analyze interpret report archive customize Unlock the benefits of image analysis. Image analysis is an integrated part of Aperio s digital
More informationHistology Pattern Recognition Software in Investigative Pathology
Histology Pattern Recognition Software in Investigative Pathology J. Webster, DVM, PhD, DACVP Laboratory of Cancer Biology and Genetics National Cancer Institute, Bethesda, MD Pathology Visions 2011 November
More informationBIMM18 Dec 20 th - Flow cytometry in clinical diagnostics
BIMM18 Dec 20 th - Flow cytometry in clinical diagnostics I. B cell leukemia and lymphomas Immunophenotyping as part of the diagnostic work- up of hematologic malignancies offers a rapid and effective
More informationCase Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID 676913, 5 pages http://dx.doi.org/10.1155/2014/676913 Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic
More informationHistocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)
Clinical Laboratory s of Practice The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services
More informationCASE REPORT AND REVIEW OF THE LITERATURE
Page 76 / SA ORTHOPAEDIC JOURNAL Summer 2009 C ASE R EPORT AND R EVIEW OF THE L ITERATURE Low-secretory multiple myeloma HF Visser MBChB(Pret) Senior Registrar, Department Orthopaedic Surgery, University
More informationLaboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities
Immunopathology / Persistence of IFE MGUS Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities David L. Murray, MD, PhD, 1 Justin L. Seningen, MD, 1 Angela Dispenzieri, MD,
More informationADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN
ACCOUNT LOGIN 1. Create an account. To set up your account for our online order entry and reporting system, please go to: https://diagnostics.adaptivebiotech.com/account/login. After signing up, please
More informationSTTARR Image Analysis Core Facility UHN Pathology Validation Core
STTARR Image Analysis Core Facility UHN Pathology Validation Core Quantitative Tools for Pathology Research OMPRN Pathology Matters Conference, October 2017 www.sttarr.com STTARR Image Analysis Core Facility
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL GENERAL FORMS AND GUIDELINES MYELOMA FORMS CHAPTER 16D REVISED: SEPTEMBER 2016
MYELOMA FORMS The guidelines and figures below are specific to Myeloma studies. The information in this manual does NOT represent a complete set of required forms for any myeloma study. Please refer to
More informationCAP Accreditation Checklists 2017 Edition
CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
More informationCOPYRIGHTED MATERIAL. Tissue Preparation and Microscopy. General Concepts. Chemical Fixation CHAPTER 1
CHAPTER 1 Tissue Preparation and Microscopy General Concepts I. Biological tissues must undergo a series of treatments to be observed with light and electron microscopes. The process begins by stabilization
More informationSerum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins
Immunopathology / DETECTING SUBTLE FLC-PRODUCING M PROTEINS Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Nasir A, Bakshi,
More informationA novel assessment of the quality of immunohistostaining overcomes the limitations of current methods
ARTICLE IN PRESS Pathology Research and Practice 204 (2008) 323 328 ORIGINAL ARTICLE A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods Avi Eisenthal,
More information2111: ALL Post-HCT. Add/ Remove/ Modify. Manual Section. Date. Description. Comprehensive Disease- Specific Manuals
2111: ALL Post-HCT The Acute Lymphoblastic Leukemia Post-HCT Data Form is one of the Comprehensive Report Forms. This form captures ALL-specific post-hct data such as: planned treatments post-hct, the
More informationSmoldering Multiple Myeloma
Smoldering Multiple Myeloma S. Vincent Rajkumar Professor of Medicine Mayo Clinic Scottsdale, Arizona Rochester, Minnesota Jacksonville, Florida Mayo Clinic College of Medicine Mayo Clinic Comprehensive
More informationSurvey of Neural Networks in Digital Pathology and Pathology Workflow
Survey of Neural Networks in Digital Pathology and Pathology Workflow Christianne Dinsmore 1 1 Department of Computing and Digital Media DePaul University Chicago, IL Abstract Digital pathology has already
More informationDIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Majalah Patologi Klinik Indonesia dan Laboratorium Medik Page 196 2018 March; 24(2): 196-200 p-issn 0854-4263 e-issn 2477-4685 Available
More informationCME/SAM. Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics
Limited Flow Cytometry Panels on Bone Marrow Specimens Reduce Costs and Predict Negative Cytogenetics Douglas G. Hoffmann, MD, and Burton H. Kim, MD From the Department of Pathology, Wellstar Health System,
More informationBUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.
BUILT TO CONCENTRATE Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care. DELIVER PERSONALIZED MEDICINE Every patient has a unique biology
More informationEDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS
Commentary provided by: Louann W. Lawrence, Dr.PH, MLS (ASCP) Professor Emeritus, Retired Louisiana State University Health Sciences Center New Orleans, LA EDUCATIONAL COMMENTARY LABORATORY EVALUATION
More informationClinico hematological profile of multiple myeloma in tertiary care Hospital, Pune
Original article Clinico hematological profile of multiple myeloma in tertiary care Hospital, Pune Dr. Sagale MS, Dr. Dangmali DP, Dr. Rane SR, Dr. Kulkarni KK, Dr. Puranik SC Department of Pathology,
More informationGenomeMe. GeneAb TM BRAF V600E. Clone: IHC600 Source: Mouse Monoclonal Positive Control: Colorectal Adenocarcinoma
GeneAb TM BRAF V600E Clone: IHC600 Source: Mouse Monoclonal Positive Control: Colorectal Adenocarcinoma 1. Intended Use This antibody is intended for in vitro diagnostic (IVD) use. The BRAF V600E (IHC600)
More informationNEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM. Crosswalk of adopted revisions to Cytopathology Standards
1 (CY S1) If the primary specimen is cellular, or examination at the cellular level is requested, the laboratory must hold a valid permit in the category of cytopathology. Examination of nongynecologic
More informationSOP# version e1.0 Material Handling and Documentation TMA's from Paraffin Embedded Tissue Blocks
CTRNet Standard Operating Procedure SOP Number: 8.3.010 Version e1.0 Supersedes: SR 001.001 Effective Date 09 Jan 08 Subject: TMA's from Paraffin Embedded Tissue Blocks Category Material Handling and Documentation
More informationinitial single-cell analysis, with a pragmatic focus on surface markers with the highest potential for
Supplementary Figure 1: Summary of the exclusionary approach to surface marker selection for initial single-cell analysis, with a pragmatic focus on surface markers with the highest potential for protein
More informationWhat do you do, with an M protein?
What do you do, with an M protein? Cancer Day for Primary Care Emily Rimmer MD FRCPC January 31, 2014 emily.rimmer@cancercare.mb.ca Disclosure of Potential for Conflict of Interest Name of presenter: Emily
More informationUrine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples
Immunopathology / Electrophoresis of Unconcentrated Urine Samples Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Anja C. Roden, MD,
More informationPCCS Growth Media, Cell Tagging, Cell Separation Final Assignment. Igneris Rosado-Erazo. Panama College of Cell Science
Running Head: Growth Media, Cell Tagging, Cell Separation PCCS Growth Media, Cell Tagging, Cell Separation Final Assignment Igneris Rosado-Erazo Panama College of Cell Science In partial fulfillment of
More informationLABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING. First Edition Australasian Cytometry Society Laboratory Assessment Document
LABORATORY ASSESSMENT OF HAEMATOLOGY ONCOLOGY IMMUNOPHENOTYPING First Edition 2018 Australasian Cytometry Society Laboratory Assessment Document Paper-based publications This work is copyright. You may
More informationIntegrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA
Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Scott W Binder MD Pritzker Professor of Clinical Pathology and Dermatology Senior Vice Chair Director, Pathology Clinical Services
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Pr e- Transformed Ig Su rf ace Su rf ace Secre ted Myelom a
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pr e- B-ce ll B-ce ll Transformed B-ce ll Plasma cell Ig Su rf ace Su rf ace Secre ted Major malignant
More informationDIAGNOSE AND TREAT WITH ANTIBODIES THAT RECOGNIZE NATIVE HUMAN PROTEIN EPITOPES IN BLOOD AND TISSUE
DIAGNOSE AND TREAT WITH ANTIBODIES THAT RECOGNIZE NATIVE HUMAN PROTEIN EPITOPES IN BLOOD AND TISSUE EXECUTIVE SUMMARY Oncologists reviewing blood and tissue test results face the same problems: Is the
More informationPERFECT-COUNT MICROSPHERES
PERFECT-COUNT MICROSPHERES Perfect-Count Microspheres-Product code PCB-100 for 100 tests Introduction In recent years, the determination of absolute cell counts has been shown to be relevant in different
More informationHevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies
Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies AR Bradwell. University of Birmingham and Binding Site Ltd How good are tests for monoclonal monoclonal proteins?
More informationEffective Health Care Program
Comparative Effectiveness Review Number 73 Effective Health Care Program Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background
More informationElectron microscopy technology of reticulocytes after sorting with
Electron microscopy technology of reticulocytes after sorting with magnetic beads The Cell Analysis Center Scientific Bulletin Part 2 For efficient analysis of cells, sorting of the target cells is crucial.
More informationLiquid. This product is shipped with dry ice. Upon receipt, store it immediately at the temperature recommended below.
PRIME-XV MSC Expansion SFM PRIME-XV MSC Expansion SFM is a serum-free complete medium optimized for the maintenance and expansion of purified human MSCs. This product does not contain antibiotics. Catalog
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Mateos M-V, Hernández M-T, Giraldo P, et al. Lenalidomide plus
More informationUse of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count
Annals of Clinical & Laboratory Science, vol. 34, no. 3, 2004 307 Use of an Automated Hematology Analyzer and Flow Cytometry to Assess Bone Marrow Cellularity and Differential Cell Count Myungshin Kim,
More informationPhiladelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant
Philadelphia College of Osteopathic Medicine Annual Progress Report: 2010 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The Philadelphia College of Osteopathic Medicine
More informationDiagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
Hutchison et al. BMC Clinical Pathology 2012, 12:12 TECHNICAL ADVANCE Open Access Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
More informationLaboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology
Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Francis E. Sharkey, MD, FCAP University of Texas Health Science Center, San Antonio, TX Richard W. Brown, MD, FCAP Memorial
More informationHIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC
HIGH SCHOOL STUDENT SCIENCE WEEK St. Paul s Hospital Vancouver, BC Sponsors 2 AGENDA Location: UBC James Hogg Research Centre (JHRC), St. Paul s Hospital, Room 166 Burrard Building, 1081 Burrard Street,
More informationMultiple Myeloma: Diagnosis And Treatment READ ONLINE
Multiple Myeloma: Diagnosis And Treatment READ ONLINE If you are searching for a book Multiple Myeloma: Diagnosis and Treatment in pdf form, in that case you come on to the correct website. We presented
More informationOnline Supplement ALVEOLAR CELL SENESCENCE IN PATIENTS WITH PULMONARY EMPHYSEMA. Takao Tsuji, Kazutetsu Aoshiba, and Atsushi Nagai
Online Supplement ALVEOLAR CELL SENESCENCE IN PATIENTS WITH PULMONARY EMPHYSEMA Takao Tsuji, Kazutetsu Aoshiba, and Atsushi Nagai MATERIALS AND METHODS Immunohistochemistry Deparaffinized tissue sections
More information2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology. Gerald A. Hoeltge, MD, FCAP July 17,
2013 Continuing Compliance Master Series Checklist Updates for Anatomic Pathology Gerald A. Hoeltge, MD, FCAP July 17, 2013 www.cap.org Today s Presenter Gerald A. Hoeltge, MD FCAP Chair, Checklists Committee
More informationADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN
ADAPTIVE BIOTECHNOLOGIES DIAGNOSTIC PORTAL: ACCOUNT LOGIN 1. Create an account. To set up your account for our online order entry and reporting system, please go to: https://diagnostics.adaptivebiotech.com/account/login.
More informationManagement of Multiple Myeloma: The Changing Paradigm
Management of Multiple Myeloma: The Changing Paradigm High-Dose Chemotherapy and Stem Cell Transplantation in the Era of Novel Therapies Larry Anderson, MD, PhD Multiple Myeloma and Stem Cell Transplant
More informationGenASIs TM Cytogenetics Suite
GenASIs TM Cytogenetics Suite FDA 510(k) cleared for the following GenASIs applications: ALK, BandView, FISHView, UroVysion, CEP XY & HER2/neu FISH per the description found on the back page of this booklet.
More informationAriol. Clinical IHC and FISH Breast Marker Analysis Quality. Efficiency. Confidence.
Ariol Clinical IHC and FISH Breast Marker Analysis Quality. Efficiency. Confidence. 3 Behind every breast slide in your laboratory is a woman waiting for life changing answers With over 1.25 million women
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
More informationGeneral Comments. Misinformation in Immunohistochemistry. Common Misinformation s in Immunohistochemistry 4/13/2017
Common Misinformation s in Immunohistochemistry Tri State Meeting May 3, 2017 Steven Westra Reagent Product Specialist Leica Biosystems Misinformation in Immunohistochemistry Flood of New Markers Diagnostic
More informationProduct Datasheet. CD31/PECAM-1 Antibody (C31.7) NBP mg. Unit Size: 0.1 mg. Store at 4C. Publications: 1
Product Datasheet CD31/PECAM-1 Antibody (C31.7) NBP2-15188-0.1mg Unit Size: 0.1 mg Store at 4C. Publications: 1 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/nbp2-15188
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK HSL (nalytics) LLP ccredited to Department of Parasitology HSL nalytics (LLP)
More informationPrinciples And Procedures
Product Identification Cat. No. Description 44674 Lambda Light Chain 0,1 M (Lamb14) 44675 Lambda Light Chain 1 M (Lamb14) 44326 Lambda Light Chain RTU M (Lamb14) Symbol Definitions P C A E S DIL DOC# DIS
More informationCarl Zeiss MicroImaging AIS. Digital Pathology The Future. Andrew Lesniak Director, Product Management
Carl Zeiss MicroImaging AIS Digital Pathology The Future Andrew Lesniak Director, Product Management Defined Industry Needs Computer Aided Imaging and Analysis will play a key role in the increase of Diagnostics
More informationThe Nuclear Area Factor (NAF): a measure for cell apoptosis using microscopy and image analysis
The Nuclear Area Factor (NAF): a measure for cell apoptosis using microscopy and image analysis Mark A. DeCoster Department of Biomedical Engineering and Institute for Micromanufacturing, Louisiana Tech
More informationReduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method
Coagulation and Transfusion Medicine / REDUCTION OF THE PLTELET REVIEW RTE Reduction of the Platelet Review Rate Using the Two-Dimensional Platelet Method Deanne H. Chapman, MT(SCP)SH, 1 Jonn Hardin, MT,
More informationISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development
ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the
More informationAppendix B. The Curriculum in Cytotechnology for Entry-level Competencies
Preface Information: Appendix B The Curriculum in Cytotechnology for Entry-level Competencies This Curriculum in Cytotechnology was developed by the CPRC with input from cytopathology professionals to
More informationThe clinical utility of IPF in thrombocytopenia
The clinical utility of IPF in thrombocytopenia Platelets platelets Platelets are the smallest blood cells which are released by cytoplasmic blebbing of megakaryocytes with an average size of 2um. Normal
More informationDiagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory
Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. Learning Objectives Compare traditional
More informationBilling Contact: Phone: Type of Research: NIH Funded Industry Funded Department Funded Study Name: CTRC Protocol: Start Date: End Date:
Please submit this application to CPRS@mednet.ucla.edu prior to beginning your research protocol. Please allow up to 2-3 weeks for the processing and approval of this application. All UCLA studies using
More informationRapid Method for Permanent Slide Preparation of Colonies in Soft Agar Cultures
International Journal of Cell Cloning 4: 368-374 (1986) Rapid Method for Permanent Slide Preparation of Colonies in Soft Agar Cultures Jazbieh Moeui, Francis Ali-Osman, Martin J. Murphy, Jr. Hipple Caqcer
More informationImmunoglobulin / free light chain ratio
Immunoglobulin / free light chain ratio 1 1 2 Kiyotaka FUJITA Katsunori TAKAHASHI Ikunosuke SAKURABAYASHI FLC IgG, IgA, IgM, IgD, IgE 5 1 1 H 1 L H,,,, L 2 monoclonal immunoglobulinemia : M L L H 40 H
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationASSESSMENT OF CLINICAL FLOW CYTOMETRY LABORATORY PRACTICE. First Edition Australasian Cytometry Society Laboratory Assessment Document
ASSESSMENT OF CLINICAL FLOW CYTOMETRY LABORATORY PRACTICE First Edition 2018 Australasian Cytometry Society Laboratory Assessment Document Paper-based publications This work is copyright. You may reproduce
More informationImmunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016
Immunological Techniques in Research and Clinical Medicine Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Antibodies Remarkable Tools for Research and Diagnosis You can make an antibody
More informationRestrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials
Restrooms Cell phones on silent/vibrate Refreshments Patient resource materials This presentation should not replace discussions with your healthcare provider, but seeks to provide information and resources
More informationTELE-HEMATOLOGY: CRITICAL DETERMINANTS FOR SUCCESSFUL IMPLEMENTATION
Blood First Edition From Paper, www.bloodjournal.org prepublished by online guest on September July 4, 2018. 11, For 2003; personal DOI use 10.1182/blood-2003-05-1615 only. TELE-HEMATOLOGY: CRITICAL DETERMINANTS
More informationGenomeMe. GeneAbTM Her2/Neu. Clone: IHC002 Source: Mouse Monoclonal Positive Control: Breast Carcinoma
GeneAbTM Her2/Neu Clone: IHC002 Source: Mouse Monoclonal Positive Control: Breast Carcinoma 1. Intended Use This antibody is intended for in vitro diagnostic (IVD) use. The Her2/Neu (IHC002) antibody is
More informationCHAP10-CPTcodes _final doc Revision Date: 1/1/2018
CHAP10-CPTcodes80000-89999_final10312017.doc Revision Date: 1/1/2018 CHAPTER X PATHOLOGY / LABORATORY SERVICES CPT CODES 80000-89999 FOR NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL FOR MEDICARE SERVICES
More informationSchool of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15
School of Allied Medical Sciences Course Description Guide Associate in Medical Laboratory Sciences Page 1 of 15 Program Name & Definition: Associate in Medical Laboratory Sciences Laboratory sciences
More informationM1741 Validating a Whole Slide Imaging System A Case Based Approach to the CAP Guidelines
M1741 Validating a Whole Slide Imaging System A Case Based Approach to the CAP Guidelines Brent T. Tan, MD, PhD, FCAP Objectives Design a validation study for a whole slide imaging system that meets CAP
More informationPathology Facilities and Potential for Collaboration. The University of Western Australia
Pathology Facilities and Potential for Collaboration UWA Pathology and Laboratory Medicine Pathology Research Themes Experimental pathology Infection and Immunity Translational pathology Cores Core Pathology
More informationWHITE PAPER FACTORS TO CONSIDER WHEN OUTSOURCING BIOREPOSITORY SERVICES
WHITE PAPER FACTORS TO CONSIDER WHEN OUTSOURCING BIOREPOSITORY SERVICES ppdi.com May 2012 EXECUTIVE SUMMARY Many pharmaceutical/biotechnology companies, government agencies and academic institutions concerned
More informationSignificance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation
Original Article Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation Sara L. Hall, 1 Jill Tate, 2 Devinder Gill, 1,3 *Peter Mollee 1,3
More informationSupplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence
1 5 6 7 8 9 10 11 1 1 1 Supplementary Figure 1. Characterization of the POP transcriptional and post-transcriptional regulatory elements. (A) POP nucleotide sequence depicting the consensus sequence for
More informationDr Karen Whale and Tony Van Galen. Anatomical Pathology Royal Hobart Hospital
Dr Karen Whale and Tony Van Galen Anatomical Pathology Royal Hobart Hospital 821 in Australia in 2016 266 in Victorian hospitals Royal Hobart Hospital State referral lab for renal biopsies 49 transplant
More informationbackground digitalization
FRAUNHOFER Institute For integrated circuits IIS Microscopy SOFTWARE AND SYSTEMS FOR HISTOLOGY 1 Background Examination and assessment of tissue samples by the pathologist represent an essential element
More information